Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome (vol 142, pg 310, 2003)

被引：0
|
作者：
Veyradier
机构：
来源：
JOURNAL OF PEDIATRICS | 2003年 / 142卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：616 / 616
页数：1
相关论文
共 35 条
  • [21] Von-Willebrand factor cleaving protease (ADAMTS-13) activity in various thrombotic, hemolytic and autoimmune disorders
    Böhm, M
    Miesbach, W
    Krause, M
    Vigh, T
    Scharrer, I
    33RD HEMOPHILIA SYMPOSIUM: HAMBURG 2002, 2004, : 159 - 164
  • [22] Von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome
    Tsai, HM
    Chandler, WL
    Sarode, R
    Hoffman, R
    Jelacic, S
    Habeeb, RL
    Watkins, SL
    Wong, CS
    Williams, GD
    Tarr, PI
    PEDIATRIC RESEARCH, 2001, 49 (05) : 653 - 659
  • [23] Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome
    Han-Mou Tsai
    Wayne L Chandler
    Ravindra Sarode
    Robert Hoffman
    Srdjan Jelacic
    Rebecca L Habeeb
    Sandra L Watkins
    Craig S Wong
    Glyn D Williams
    Phillip I Tarr
    Pediatric Research, 2001, 49 : 653 - 659
  • [24] Novel mutations in the Adamts 13 gene in autosomal recessive von Willebrand factor-cleaving protease deficiency causing thrombotic thrombocytopenic purpura (TTP).
    Assink, K
    Schiphorst, R
    van de Kar, N
    Allford, S
    Karpman, D
    Brichard, B
    Etzioni, A
    Monnens, L
    van den Heuvel, L
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 130A - 130A
  • [25] Clinical Significance of von Willebrand Factor-Cleaving Protease (ADAMTS13) Deficiency in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
    Kim, Young Keun
    Lee, Jongwook
    Lee, Kyung-A
    Kwon, Hee Uk
    INFECTION AND CHEMOTHERAPY, 2009, 41 (02): : 78 - 81
  • [26] Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): A simplified laboratory assessment of Von Willebrand factor-cleaving protease (VWF-CP) activity.
    Elliott, MA
    Daniels, TM
    Owen, WG
    Nichols, WL
    BLOOD, 1999, 94 (10) : 14A - 14A
  • [27] Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies:: diagnostic experience 2001/2002 of a single research laboratory
    Studt, JD
    Hovinga, JAK
    Alberio, L
    Bianchi, V
    Lämmle, B
    SWISS MEDICAL WEEKLY, 2003, 133 (23-24) : 325 - 332
  • [28] Relation between von Willebrand factor-cleaving protease (ADAMTS13) activity and presenting features and outcomes of thrombotic thrombocytopenic purpura (TTP).
    Vesely, SK
    George, JN
    Lammle, B
    Studt, JD
    Alberio, L
    El-Harake, MA
    BLOOD, 2002, 100 (11) : 684A - 684A
  • [29] ADAMTS-13 (VON WILLEBRAND FACTOR-CLEAVING PROTEASE) ACTIVITY IN THE EARLY AND LATE PHASES AFTER TRANSIENT ISCHAEMIC ATTACK OR ISCHAEMIC STROKE
    McCabe, D. J. H.
    Starke, R.
    Harrison, P.
    Brown, M. M.
    Sidhu, P. S.
    Mackie, I. J.
    Machin, S. J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (01): : 103 - 104
  • [30] Deficiency of von willebrand factor (VWF)-cleaving protease activity does not discriminate thrombotic thrombocytopenic purpura (TTP) from the hemolytic uremic syndrome (HUS).
    Mannucci, PM
    Galbusera, M
    Noris, M
    Canciani, MT
    Remuzzi, G
    BLOOD, 2001, 98 (11) : 754A - 754A
1234